ESLA · Estrella Immunopharma, Inc.
$0.72
-0.02 (-3.12%)
At close · Aug 7
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 18, 2026
Market Cap
$31.09M
Shares
43.03M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jia Dengyao | member of the Board | Appointed | 2025-09-26 |
| Hong Zhang | member of the Company's Board of Directors | Appointed | 2024-08-20 |
| Hong Zhang | Chairperson | Appointed | 2024-08-20 |